{"entity":{"type":"insider","cik":"0001626892","url":"/insider/0001626892","json_url":"/insider/0001626892.json","name":"Moseley Annemarie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2015-07-06","last":"2016-12-05","span_basis":"filed_date"},"name_variants":[{"name":"Moseley Annemarie","source":"filing","n_filings":4,"first_seen":"2015-07-06","last_seen":"2016-12-05"}],"transactions":[{"id":2716142,"accession":"0001358403-16-000299","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-16-000299","line_url":"/filing/0001358403-16-000299#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14458.0,"shares_display":"14,458","price_per_share":17.1746,"price_display":"17.17","price_state":"stated","total_value":248310.3668,"total_display":"248,310.37","shares_owned_after":10984.0,"shares_owned_after_display":"10,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":2716139,"accession":"0001358403-16-000299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-16-000299","line_url":"/filing/0001358403-16-000299#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10542.0,"shares_display":"10,542","price_per_share":18.0416,"price_display":"18.04","price_state":"stated","total_value":190194.5472,"total_display":"190,194.55","shares_owned_after":442.0,"shares_owned_after_display":"442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":2685052,"accession":"0001358403-16-000208","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001358403-16-000208","line_url":"/filing/0001358403-16-000208#line-4","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18235.0,"shares_display":"18,235","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":237055.0,"total_display":"237,055.00","shares_owned_after":251.0,"shares_owned_after_display":"251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":2685047,"accession":"0001358403-16-000208","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-16-000208","line_url":"/filing/0001358403-16-000208#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6765.0,"shares_display":"6,765","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":87945.0,"total_display":"87,945.00","shares_owned_after":251.0,"shares_owned_after_display":"251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":3363979,"accession":"0001358403-16-000130","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-16-000130","line_url":"/filing/0001358403-16-000130#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32700.0,"shares_display":"32,700","price_per_share":19.0089,"price_display":"19.01","price_state":"stated","total_value":621591.03,"total_display":"621,591.03","shares_owned_after":2551.0,"shares_owned_after_display":"2,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider"},{"id":3363976,"accession":"0001358403-16-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-16-000130","line_url":"/filing/0001358403-16-000130#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":19.9578,"price_display":"19.96","price_state":"stated","total_value":45902.94,"total_display":"45,902.94","shares_owned_after":251.0,"shares_owned_after_display":"251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider"},{"id":8870990,"accession":"0001358403-15-000038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001358403-15-000038","line_url":"/filing/0001358403-15-000038#line-3","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33950.0,"shares_display":"33,950","price_per_share":20.5959,"price_display":"20.60","price_state":"stated","total_value":699230.805,"total_display":"699,230.80","shares_owned_after":1172.0,"shares_owned_after_display":"1,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"},{"id":8870988,"accession":"0001358403-15-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001358403-15-000038","line_url":"/filing/0001358403-15-000038#line-2","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001626892","owner_name":"Moseley Annemarie","owner_url":"/insider/0001626892","role":"Officer (COO/EVP Clinical Development)","officer_title":"COO/EVP Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":21.3253,"price_display":"21.33","price_state":"stated","total_value":22391.565,"total_display":"22,391.56","shares_owned_after":122.0,"shares_owned_after_display":"122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358403","name":"BELLICUM PHARMACEUTICALS, INC","url":"/issuer/0001358403","role":"Officer (COO/EVP Clinical Development)","n_filings":4,"first_seen":"2015-07-06","last_seen":"2016-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001626892","retrieved_at":"2026-08-21T16:21:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}